FRANKFURT, Feb 8 (Reuters) - Dermapharm shares are being placed at 28 euros ($34.33) apiece in the German drugmaker’s initial public offer (IPO), at the middle of an indicative price range of 26 to 30 euros, a person familiar with the transaction said on Thursday.

Dermapharm stock is due to start trading on the Frankfurt stock exchange on Friday, making it Germany’s first flotation in 2018, which is expected to be a blockbuster year for IPOs.